Contrast-induced nephropathy;Nefropatia de contraste

Acta Medica Portuguesa

Volumn 24, Issue 5, 2011, Pages 809-820

  Santos, Ricardo Oliveira ^a   Malvar, Beatriz ^a   Silva, Rui ^a   Ramalho, Vítor ^a   Pessegueiro, Pedro ^a   Amoedo, Manuel ^a   Aniceto, João ^a   Pires, Carlos ^a  

^a Hospital do Espirito Santo   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BICARBONATE; CONTRAST MEDIUM; CREATININE; ISOTONIC SOLUTION;

ARTICLE; CONGESTIVE HEART FAILURE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CYTOTOXICITY; DEHYDRATION; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG COST; DRUG MEGADOSE; FLUID THERAPY; HUMAN; HYPOXIA; KIDNEY BLOOD VESSEL; KIDNEY FAILURE; KIDNEY MEDULLA; PATHOGENESIS; RENAL PROTECTION; RISK BENEFIT ANALYSIS; RISK FACTOR; SENESCENCE; VASOCONSTRICTION;

CLINICAL PROTOCOLS; CONTRAST MEDIA; HUMANS; IODINE COMPOUNDS; KIDNEY DISEASES; RISK FACTORS;

EID: 84857171540     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. The ACT Trial Investigators: Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropathy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy. Trials 2009;10:38
2. Rudnick M, Feldman H: Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 2008;3(1):263-272
3. Hou SH, Bushinsky DA, Wish JB, Cohan JJ, Harington JT: Hospital acquired renal insufficiency: a prospective study. Am J Med 1993;74:243-8
4. Nash K, Hafez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6
5. Bartoreli A, Marenzi G: Contrast-induced nephropathy. J Interv Cardiol 2008;21(1):74-85
6. Schweiger M, Chambers C, Davidson C et al: Prevention of contrast-induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007;69(1):135-140
7. Pucelikova T, Dangas G, Mehran R: Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008;71(1):62-72.
8. Redan D, Laville M, Garovic V: Contrast-induced nephropathy and its prevention: what do we really know from evidencebased findings? J Nephrol 2009; 22:333-351
9. Rudnick MR, Tumlin JA: Pathogenesis, clinical features and diagnosis of radiocontrast media-induced acute kidney injury (acute renal failure). UpToDate version 17.1. February 2009
10. Toprak O: Conflicting and new risk factors for contrast induced nephropathy. J Urol 2007;178(6):2277-83
11. Meschi M, Detrenis S, Musini S, Strada E, Savazzi G: Facts and fallacies concerning the prevention of contrast medium-induced nephropathy. Crit Care Med 2006;34:2060-8
12. Tumlin J, Stacul F, Adam A et al: Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98:14K-20K
13. Wong GTC, Irwin MG: Contrast-induced nephropathy. Br J Anaesth 2007;99(4):474-483
14. Dobrota M, powell CJ, Holt z E, Walin A, Vik H: Biochemical and morphological effects of contrast media on the kidney. Acta Radiol Suppl 1995;399:196-203
15. Person PB, Hansel P, Lis P: Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22
16. McCulough PA, Dandberg KR: Epidemiology of contrastinduced nephropathy. Rev Cardiovasc Med 2003;4(Suppl.5):1172-81
17. Bostom AG, Kronenberg F, Ritz E: Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002;13:2140-4
18. LEVEY AS, STEVENS LA, SCHMID CH et al: A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 2009;150(9):604-612
19. Thomsen HS, Morcos SK, Baret BJ: Contrast-Induced Nephropathy. The Wheel Has Turned 360 Degrees. Acta Radiol 2008;49:646-657
20. McCart CS, Becker JA: Multiple myeloma and contrast media. Radiology 1992;183:519-521
21. Mehran R, Aymong ED, Nikolsk E et al: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004;44:1393-9
22. Baret BJ, Parfrey PS: Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379-386
23. Fin WF: The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 2006;21(Suppl 1):i2-10
24. Deray G: Dialysis and iodinated contrast media. Kidney Int 2006;69:S25-9
25. Trivedi HS, Moore H, Nasr S et al: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephropathy. Nephron Clin Pract 2003;93:C29-C34
26. Mueler C, Buerkle G, Buetner HJ et al:. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336
27. Weisbord SD, Palevsk PM: Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008;3:273
28. Merten GJ, Burgess WP, Gray LV et al: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34
29. Ozcan EE, Guneri S, Akdeniz B et al: Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy: a comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures: a single-center prospective controlled trial. Am Heart J 2007;154:539-544
30. Recio-Mayoral A, Chaparro M, Prado B et al: The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 2007;49:1283-8
31. Briguori C, Airoldi F, D'Andrea D et al: Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007;115:1211-7
32. Masuda M, Yamada T, Mine T et al: Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007;100:781-6.
33. Brar SS, Shen AY, Jorgensen MB et al: Sodium bicarbonate versus sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008;300:1038-46
34. Maioli M, Toso A, Leoncini M et al: Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008;52:599-604
35. NAVANEETHAN SD, SINGH S, APPASAMY S et al: Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Am J Kidney Dis 2009;53:617-627
36. BRAR SS, SWAPNIL H, DANGAS G et al: Sodium Bicarbonate for the Prevention of Contrast Induced Acute Kidney Injury: A Systematic Review and Meta-analysis. Clin J Am Soc Nephrol 2009;4:1584-92
37. HOSTE EA, DE WAELE JJ, GEVAERT SA et al: Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2010;25(3):747-758
38. Bourin M, Joliet P, Balereau F: An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet 1997;32:180-193
39. Rudnick MR, Tumlin JA:. Prevention of radiocontrast mediainduced acute kidney injury (acute renal failure). UpToDate version 17.1. February 2009
40. Kat zberg R, Baret B: Risk of contrast-induced nephropathy with the intravenous administration of iodinated contrast media. Radiology 2007;243:622-8
41. Baret BJ, Carlisle EJ: Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8
42. Aspelin P, Aubry P, Franson SG, Straser R, Wilenbrock R, Berg KJ: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9
43. Jo SH, Youn TJ, Koo BK et al: Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006;48:924-930
44. McCulough PA, Bertrand ME, Brinker JA, Stacul F: A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006;48:692-699
45. Goldfarb S, McCulough PA, McDermott J, Gay S: Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology and interventional cardiology. Mayo Clin Proc 2009;84(2):170-9
46. Kely GS: Clinical applications of N-acetylcysteine. Altern Med Rev 1998;3:114-127
47. Fishbane S, Durham JH, Marzo K, Rudnick M: N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251-260
48. Web JG, Pate GE, Humphries KH et al: A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 2004;148:422-9
49. Baker CS, Wragg A, Kumar S et al: A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003;41:2114-8
50. Marenzi G, Assaneli E, Marana I et al: N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82
51. Spargias K, Alexopoulos E, Kyrzopoulos S et al: Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-42.
52. Onbasili AO, Yeniceriglu Y, Agaoglu P et al: Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures. Heart 2007;93:698-702
53. Attallah N, Yassine L, Musial J et al: The potential role of statins in contrast nephropathy. Clin Nephrol 2004;62:273-8
54. Khanal S, Attallah N, Smith DE et al: Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 2005;118:843-9
55. Jo SH, Koo BK, Park JS et al: Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study. Am Heart J 2008;155(3):499.e1-8
56. Yoshida S, Kamihata H, Nakamura S et al: Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. J Cardiol 2009;54(2):192-8
57. Zhao JL, Yang YJ, Zhang YH et al: Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol. 2008;126(3):435-6
58. Patti G, Nusca A, Chelo M et al: Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008;101(3):279-285
59. Ix JH, McCuloch CE, Chertow GM: Theophylline for the prevention of radiocontrast nephropathy: A meta-analysis. Nephrol Dial Transplant 2004;19:2747-53
60. Shamas NW, Kapalis MJ, Haris M, McKiney D, Coyne Ep: Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. Invasive Cardiol 2001;13:738-740
61. Vogt B, Ferari P, Schonholzer C et al: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001;111:692-8
62. Lee PT, Chou KJ, Liu CP et al: Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 2007;50:1015-20
63. Marenzi G, Marana I, Lauri G et al: The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1331-8
64. Marenzi G, Lauri G, Campodonico J et al: Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006;119:155-162